STAT July 2, 2024
John Wilkerson

A looming anti-China biotechnology bill has spooked U.S. life sciences companies, according to a new report.

The report by the China-based L.E.K. Consulting quantifies what until now has been mostly a vibe check. At this year’s Biotechnology Innovation Organization’s international conference, multiple biotech companies told STAT they plan to switch from...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Survey / Study, Trends
Judge kicks out another Medicare price negotiation challenge
Pharma Pulse 7/4/24: Colder Temperatures May Worsen Asthma Symptoms, New FDA Approved ALZ Drug to Accelerate New Era of Treatment & more
Research harnesses machine learning and imaging to give insight into stem cell behavior
HHS Awards Moderna $176 Million to Develop Pandemic-Ready Influenza Vaccine
The Novo Nordisk Foundation Believes Quantum Computing Poised to Revolutionize Healthcare & Drug Discovery

Share This Article